PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
17-Jul-2024 Velocity appoints ex-IQVIA and Science 37 Executive Mike Zaranek as CFO Velocity Clinical Research
17-Jul-2024 Successful completion of eighth harvest of 2024 On track for fifteen harvest year Celadon Pharmaceuticals Plc
17-Jul-2024 ONTOFORCE Achieves ISO 27001:2022 Certification: A Milestone in Information Security and Trust ONTOFORCE
17-Jul-2024 CHEPLAPHARM reorganises Management Team Cheplapharm AG
17-Jul-2024 DOUGLAS Group raises sales forecast for the financial year 2023/24 and sells online pharmacy Disapo Douglas AG
16-Jul-2024 Eckert & Ziegler Again Increases Sales and Earnings Compared to Previous Year. Profit Forecast Raised for 2024. Eckert & Ziegler SE
16-Jul-2024 Driving subcutaneous self-injection of large volume doses: SCHOTT Pharma launches large format ready-to-use cartridges for on-body devices SCHOTT Pharma AG & Co. KGaA
15-Jul-2024 Abivax Provides Operational and Key Program Update ABIVAX
15-Jul-2024 Nyxoah Appoints Scott Holstine as Chief Commercial Officer Nyxoah SA.
15-Jul-2024 Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights in favour of Affluent Medical SA
15-Jul-2024 Sales growth Q2/2024 +14 % and H1/2024 +10 % compared to previous year; positive development in all operating areas aap Implantate AG
15-Jul-2024 Evolva Holding SA: Approval of temporary exemption from certain conditions for maintaining listing pursuant to art. 7 Listing Rules; IFRS financial statements for 2023 and half-year 2024 to be publish Evolva Holding SA
12-Jul-2024 MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market MorphoSys AG
12-Jul-2024 Drägerwerk AG & Co. KGaA: Preliminary figures H1 2024: Earnings above prior year Drägerwerk AG & Co. KGaA
12-Jul-2024 Ad hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.00 MorphoSys AG
12-Jul-2024 Newest Version of LifeSphere® Regulatory Platform Allows Organizations to Leverage Latest GenAI Technology ArisGlobal
12-Jul-2024 Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment Affluent Medical SA
11-Jul-2024 NICE recommends Ebglyss (lebrikizumab) for use in moderate to severe Atopic Dermatitis in the NHS England in eligible adolescents and adults Almirall
11-Jul-2024 Cosette Pharmaceuticals Acquires Ambien® and Ambien CR® (Zolpidem Tartrate) Tabs from Sanofi US in the US Market Cosette Pharmaceuticals
11-Jul-2024 New data shows UK life sciences failing to reach its potential Association of the British Pharmaceutical Industry (ABPI)